FHA
PRCT icon

First Horizon Advisors’s Procept Biorobotics PRCT Stock Holding History

First Horizon Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$14.1K Buy
245
+118
+93% +$6.67K ﹤0.01% 1546
2025
Q1 		$7.4K Hold
127
– – ﹤0.01% 1707
2024
Q4 		$10.2K Buy
+127
New +$10.8K ﹤0.01% 1598

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

First Horizon Advisors's PRCT Position: Q2 2025 in Review

First Horizon Advisors increased its Procept Biorobotics (PRCT) stake by 93% in Q2 2025, buying an estimated $6.67K and bringing the position to 245 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

First Horizon Advisors first reported a position in PRCT in Q4 2024 and has held it in 3 quarters since. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • First Horizon Advisors held 245 shares of Procept Biorobotics worth $14.1K as of Q2 2025.
  • First Horizon Advisors bought 118 Procept Biorobotics shares in Q2 2025, an estimated $6.67K.
  • Procept Biorobotics made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1546 holding.
  • First Horizon Advisors first reported a position in Procept Biorobotics in Q4 2024 and has held it in 3 quarters since.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.